WELCOME TO
A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
We're #hiring! If you're interested in joining our award winning team, visit our website to apply for roles: https://t.co/WGYVJcKwuw
.@ersgenomics today announced the signing of a #license agreement with Otsuka Pharmaceutical Co. Ltd.
The agreement grants access to ERS' #CRISPRCas9 genome editing technology for #research and development.
Read more: https://t.co/N573cDqfQV
.@Dotmatics today announced a licensing agreement with @CompugenInc to supply #informatics technology. The Company's #LIMS and #ELN were chosen to support Compugen's #drugdiscovery and marks Dotmatics' first implementation in Israel. Read more: https://t.co/dEMdGYDCA3
.@OXGENEofficial has announced it has been acquired by @WuXi_AppTec and will operate as part of its @Adv_Therapies, becoming its first European facility.
The acquisition supports the #RandD of cell and #gene #therapies for patients in need worldwide: https://t.co/dKbewvY6e4
.@CN_Bio today announced it has been awarded an @innovateuk grant to develop single and multi-organ models for #COVID19 research.
The funding will advance 3D lung #cellculture models to accelerate #drugdiscovery
Read more: https://t.co/OFt20tC2jq
.@ersgenomics today announced the #appointment of Jon Kratochvil as Vice-President for Business Development & #Licensing for North America.
Read more: https://t.co/wwXdqZvyMz
